Works matching IS 0257277X AND DT 2016 AND VI 64 AND IP 2


Results: 36
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Roles of A20 in autoimmune diseases.

    Published in:
    Immunologic Research, 2016, v. 64, n. 2, p. 337, doi. 10.1007/s12026-015-8677-6
    By:
    • Zhang, Min;
    • Peng, Ling-Long;
    • Wang, Ying;
    • Wang, Jian-Shu;
    • Liu, Jiao;
    • Liu, Meng-Meng;
    • Hu, Jia;
    • Song, Bin;
    • Yang, Hai-Bing
    Publication type:
    Article
    28
    29

    High-mobility group box 1 in multiple sclerosis.

    Published in:
    Immunologic Research, 2016, v. 64, n. 2, p. 385, doi. 10.1007/s12026-015-8673-x
    By:
    • Sternberg, Zohara;
    • Sternberg, Daniel;
    • Chichelli, Trevor;
    • Drake, Allison;
    • Patel, Neel;
    • Kolb, Chana;
    • Chadha, Kailash;
    • Yu, Jinhee;
    • Hojnacki, David
    Publication type:
    Article
    30
    31
    32

    Soluble mediators produced by the crosstalk between microvascular endothelial cells and dengue-infected primary dermal fibroblasts inhibit dengue virus replication and increase leukocyte transmigration.

    Published in:
    Immunologic Research, 2016, v. 64, n. 2, p. 392, doi. 10.1007/s12026-015-8675-8
    By:
    • Bustos-Arriaga, José;
    • Mita-Mendoza, Neida K.;
    • Lopez-Gonzalez, Moises;
    • García-Cordero, Julio;
    • Juárez-Delgado, Francisco J.;
    • Gromowski, Gregory D.;
    • Méndez-Cruz, René A.;
    • Fairhurst, Rick M.;
    • Whitehead, Stephen S.;
    • Cedillo-Barrón, Leticia
    Publication type:
    Article
    33

    Erratum to: Advancing drug delivery systems for the treatment of multiple sclerosis.

    Published in:
    Immunologic Research, 2016, v. 64, n. 2, p. 640, doi. 10.1007/s12026-016-8791-0
    By:
    • Tabansky, Inna;
    • Messina, Mark D.;
    • Bangeranye, Catherine;
    • Goldstein, Jeffrey;
    • Blitz-Shabbir, Karen M.;
    • Machado, Suly;
    • Jeganathan, Venkatesh;
    • Wright, Paul;
    • Najjar, Souhel;
    • Cao, Yonghao;
    • Sands, Warren;
    • Keskin, Derin B.;
    • Stern, Joel N. H.
    Publication type:
    Article
    34
    35
    36

    Follicular lymphoma: in vitro effects of combining lymphokine-activated killer (LAK) cell-induced cytotoxicity and rituximab- and obinutuzumab-dependent cellular cytotoxicity (ADCC) activity.

    Published in:
    Immunologic Research, 2016, v. 64, n. 2, p. 548, doi. 10.1007/s12026-015-8747-9
    By:
    • García-Muñoz, Ricardo;
    • López-Díaz-de-Cerio, Ascensión;
    • Feliu, Jesus;
    • Panizo, Angel;
    • Giraldo, Pilar;
    • Rodríguez-Calvillo, Mercedes;
    • Grande, Carlos;
    • Pena, Esther;
    • Olave, Mayte;
    • Panizo, Carlos;
    • Inogés, Susana
    Publication type:
    Article